SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-13-009348
Filing Date
2013-09-27
Accepted
2013-09-27 06:11:29
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2216786z10-ka.htm 10-K/A 830974
2 EX-23.1 a2216786zex-23_1.htm EX-23.1 3870
3 EX-31.3 a2216786zex-31_3.htm EX-31.3 7450
4 EX-31.4 a2216786zex-31_4.htm EX-31.4 7424
5 EX-32.2 a2216786zex-32_2.htm EX-32.2 4925
  Complete submission text file 0001047469-13-009348.txt   11915119

Data Files

Seq Description Document Type Size
6 EX-101.INS kyth-20121231.xml EX-101.INS 902858
7 EX-101.SCH kyth-20121231.xsd EX-101.SCH 62013
8 EX-101.CAL kyth-20121231_cal.xml EX-101.CAL 81807
9 EX-101.DEF kyth-20121231_def.xml EX-101.DEF 366417
10 EX-101.LAB kyth-20121231_lab.xml EX-101.LAB 1069804
11 EX-101.PRE kyth-20121231_pre.xml EX-101.PRE 525387
Mailing Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301
Business Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301 818-587-4500
KYTHERA BIOPHARMACEUTICALS INC (Filer) CIK: 0001436304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35663 | Film No.: 131117932
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1